Eton Pharmaceuticals, Inc. ETON
ETON
Eton Pharmaceuticals, Inc. RAPT
RAPT Therapeutics, Inc. FULC
Fulcrum Therapeutics, Inc. NMRA
Neumora Therapeutics, Inc. Common Stock LXRX
Lexicon Pharmaceuticals, Inc. OMER
Omeros Corporation OCGN
Ocugen, Inc. MNPR
Monopar Therapeutics Inc. LCTX
Lineage Cell Therapeutics, Inc. ADCT
ADC Therapeutics S.A.
Eton Pharmaceuticals, Inc. RAPT
RAPT Therapeutics, Inc. FULC
Fulcrum Therapeutics, Inc. NMRA
Neumora Therapeutics, Inc. Common Stock LXRX
Lexicon Pharmaceuticals, Inc. OMER
Omeros Corporation OCGN
Ocugen, Inc. MNPR
Monopar Therapeutics Inc. LCTX
Lineage Cell Therapeutics, Inc. ADCT
ADC Therapeutics S.A.
Performance
| Periode | ETON | RAPT | FULC | NMRA | LXRX | OMER | OCGN | MNPR | LCTX | ADCT |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 12.70 % | 302.91 % | 89.71 % | 126.96 % | 84.33 % | 173.00 % | 18.53 % | 119.73 % | 97.16 % | 25.15 % |
| YTD | 11.60 % | 154.60 % | 166.53 % | -0.51 % | 58.92 % | -6.50 % | 52.78 % | 238.39 % | 231.07 % | 111.50 % |
| 1Y | 25.35 % | 370.92 % | 191.86 % | -81.97 % | 60.41 % | 21.21 % | 62.32 % | 181.61 % | 241.00 % | 111.50 % |
| 3Y | 391.38 % | -77.01 % | 141.12 % | -87.94 % | -40.63 % | 413.97 % | -10.13 % | 471.79 % | 33.20 % | 30.15 % |
| 5Y | 102.92 % | -82.80 % | -2.35 % | -87.94 % | -59.24 % | -39.39 % | 358.33 % | 161.08 % | -6.32 % | -86.56 % |
| 10Y | 155.52 % | -68.08 % | -4.44 % | -87.94 % | -90.78 % | -34.98 % | -99.20 % | -43.25 % | -53.54 % | -85.73 % |
| From the beginning | 155.52 % | -68.08 % | -4.44 % | -87.94 % | -99.06 % | 5.38 % | -99.80 % | -43.25 % | -56.47 % | -85.73 % |